Kezar Life Sciences, Inc. — Director's Dealing 2018

Jun 27, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2018-06-25

Reporting Person: Fowler John Franklin (Director, CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-25	Employee Stock Option (Right to Buy)	$5.91	A	88967	Acquired	2028-04-15	Common Stock (88967)	Direct

Footnotes

F1: 100% of the shares subject to the option vested and became exercisable upon the closing of the initial public offering in accordance with its terms.